litlas
Log inCreate account

Bart Barlogie

Active 1976–2024

Also published as
BART BARLOGIE
254
Papers
67,135
Citations
139
h-index
250
i10-index

Citations

Citations per year for Bart Barlogie1948: 14 citations1968: 1 citations1977: 2 citations1978: 1 citations1979: 2 citations1980: 5 citations1981: 2 citations1982: 8 citations1983: 5 citations1984: 3 citations1985: 9 citations1986: 11 citations1987: 9 citations1988: 17 citations1989: 28 citations1990: 11 citations1991: 17 citations1992: 23 citations1993: 23 citations1994: 41 citations1995: 40 citations1996: 51 citations1997: 69 citations1998: 89 citations1999: 105 citations2000: 195 citations2001: 229 citations2002: 323 citations2003: 456 citations2004: 489 citations2005: 503 citations2006: 575 citations2007: 724 citations2008: 687 citations2009: 829 citations2010: 674 citations2011: 843 citations2012: 635 citations2013: 580 citations2014: 555 citations2015: 484 citations2016: 469 citations2017: 461 citations2018: 394 citations2019: 1,407 citations2020: 1,337 citations2021: 1,349 citations2022: 923 citations2023: 501 citations2024: 896 citations2025: 340 citations2026: 8 citations1949–1967: no citations, so these years are not shown1969–1976: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,830 citing papers, 29.9% of this breakdownItaly: 1,035 citing papers, 6.4% of this breakdownChina: 975 citing papers, 6% of this breakdownGermany: 965 citing papers, 6% of this breakdownUnited Kingdom: 938 citing papers, 5.8% of this breakdownFrance: 869 citing papers, 5.4% of this breakdownSpain: 679 citing papers, 4.2% of this breakdownCanada: 535 citing papers, 3.3% of this breakdownNetherlands: 498 citing papers, 3.1% of this breakdownGreece: 390 citing papers, 2.4% of this breakdownJapan: 384 citing papers, 2.4% of this breakdownAustralia: 354 citing papers, 2.2% of this breakdown
0%29.9%Other 22.9%

Institutions

Fields

  • Medicine67.5%
  • Biochemistry, Genetics and Molecular Biology23.9%
  • Immunology and Microbiology4.9%
  • Computer Science1.3%
  • Mathematics0.3%
  • Chemistry0.3%
  • Other1.8%

Topics

  • Multiple Myeloma Research and Treatments16.3%
  • Protein Degradation and Inhibitors6.1%
  • Peptidase Inhibition and Analysis3.4%
  • Ubiquitin and proteasome pathways3%
  • Cancer Treatment and Pharmacology2.5%
  • Chronic Lymphocytic Leukemia Research2%
  • Other66.7%

Coauthors

All papers

Open in search
  1. International Staging System for Multiple Myeloma

    Authors: Philip R. Greipp, Jesús F. San Miguel, Brian G.M. Durie, John J. Crowley, Bart Barlogie, Joan Bladé, Mario Boccadoro, J. A. Child, Hervé Avet‐Loiseau, Robert A. Kyle, Juan José Lahuerta, Heinz Ludwig, Gareth J. Morgan, Raymond Powles, Kazuyuki Shimizu, Chaim Shustik, Pieter Sonneveld, Patrizia Tosi, Ingemar Turesson, Jan Westin - Journal of Clinical Oncology 2005 cited by 2,918

  2. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

    Authors: Brian G.M. Durie, Antje Hoering, Muneer H. Abidi, S. Vincent Rajkumar, Joshua Epstein, Stephen P. Kahanic, Mohan C. Thakuri, Frederic J. Reu, Christopher M. Reynolds, Rachael Sexton, Robert Z. Orlowski, Bart Barlogie, Angela Dispenzieri - The Lancet 2016 cited by 888

  3. International uniform response criteria for multiple myeloma

    Authors: Brian G.M. Durie, J-L Harousseau, Jesús F. San Miguel, J Bladé, Bart Barlogie, Kenneth C. Anderson, Morie A. Gertz, Meletios Α. Dimopoulos, Jan Westin, Pieter Sonneveld, Heinz Ludwig, Gösta Gahrton, Meral Beksaç, John Crowley, Andrew Belch, M Boccadaro, Ingemar Turesson, D. Joshua, David H. Vesole, Robert A. Kyle, Raymond Alexanian, Guido Tricot, Michel Attal, Giampaolo Merlini, R Powles, Paul G. Richardson, Kazuyuki Shimizu, Patrizia Tosi, Gareth J. Morgan, S. Vincent Rajkumar, on behalf of the International Myeloma Working Group - Leukemia 2006 cited by 2,639

  4. The molecular classification of multiple myeloma

    Authors: Fenghuang Zhan, Yongsheng Huang, Simona Colla, Peter Stewart, Ichiro Hanamura, Sushil Gupta, Joshua Epstein, Shmuel Yaccoby, Jeffrey R. Sawyer, Bart Burington, Elias Anaissie, Klaus Hollmig, Mauricio Pineda‐Roman, Guido Tricot, Frits van Rhee, Ronald C. Walker, Maurizio Zangari, John Crowley, Bart Barlogie, John D. Shaughnessy - Blood 2006 cited by 1,142

  5. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

    Authors: Robert A. Kyle, Brian G.M. Durie, S. Vincent Rajkumar, Ola Landgren, Joan Bladé, Giampaolo Merlini, Nicolaus Kröger, Hermann Einsele, David H. Vesole, Meletios Α. Dimopoulos, Jesús F. San Miguel, Hervé Avet‐Loiseau, Roman Hájek, W M Chen, Kenneth C. Anderson, Heinz Ludwig, Pieter Sonneveld, S Pavlovsky, Antonio Palumbo, Paul G. Richardson, Bart Barlogie, Patricia T. Greipp, Robert Vescio, Ingemar Turesson, Jan Westin, Mario Boccadoro, on behalf of the International Myeloma Working Group - Leukemia 2010 cited by 876

  6. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

    Authors: Leo Rasche, Shweta S. Chavan, Owen Stephens, Pragi Patel, Ruslana G. Tytarenko, Cody Ashby, Michael Bauer, Joshua Epstein, S Deshpande, Christopher P. Wardell, Tímea Buzder, Gábor Molnár, Maurizio Zangari, Frits van Rhee, Sharmilan Thanendrarajan, Carolina Schinke, Joshua Epstein, Faith E. Davies, Brian A. Walker, Tobias Meißner, Bart Barlogie, Gareth J. Morgan, Niels Weinhold - Nature Communications 2017 cited by 419

  7. Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

    Authors: Seema Singhal, Jayesh Mehta, Raman Desikan, Dan Ayers, Paula K. Roberson, Paul Eddlemon, Nikhil C. Munshi, Elias Anaissie, Carla S. Wilson, Madhav V. Dhodapkar, Jerome B. Zeldis, David S. Siegel, John Crowley, Bart Barlogie - New England Journal of Medicine 1999 cited by 2,590

  8. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

    Authors: Brett T. Thorn, Zhichao Liu, Stephen Harris, Baitang Ning, Lei Xu, Lun Yang, Huixiao Hong, Jie Liu, Zhiguang Li, James C. Fuscoe, Leming Shi, Qiang Shi, Weigong Ge, Min Zhang, Minjun Chen, Roger Perkins, Zhining Wen, Weida Tong, Reena Philip, Uwe Scherf, Francisco Martínez-Murillo, Rong Tang, Gene Pennello, Brandon D. Gallas, Gregory Campbell, Lakshmi Vishnuvajjala, F. W. Samuelson, Živana Težak, Weijie Chen, Wendell Jones, Joel S. Parker, Fabien Campagne, Stephen J. Walker, Zhenqiang Su, Joshua Xu, Hong Fang, Feng Qian, Dhivya Arasappan, Zhenqiang Su, Russell D. Wolfinger, Padraic Neville, Tzu‐Ming Chu, Li Li, Wenjun Bao, Kelci Miclaus, Pei-Yi Tan, Wendy Czika, Federico Goodsaid, Mat Soukup, Li Zhang, Jialü Zhang, Sue Jane Wang, Lajos Pusztai, John D. Shaughnessy, Bart Barlogie, Yiming Zhou, Matthias Fischer, André Oberthuer, Yvonne Kahlert, Frank Berthold, Russell S. Thomas, J.-H Chou, Richard S. Paules, Jennifer Fostel, Pierre R. Bushel, Mark R. Fielden, Pan Du, Simon Lin, Cesare Furlanello, Giuseppe Jurman, Samantha Riccadonna, Roberto Visintainer, Xijin Ge, Dalila B. Megherbi, Manuel Madera, W. Fraser Symmans, May D. Wang, R. Mitchell Parry, Todd H. Stokes, John H. Phan, Andrea B. Moffitt, Jun Luo, John H. Zhang, Matthew Woods, Eric W. Wang, Hans Bitter, Dilafruz Juraeva, Benedikt Brors, Frank Westermann, Roland Eils, Johan Trygg, Max Bylesjö, Jie Cheng, Jing Cheng, Timothy S. Davison, Mauro Delorenzi, Vlad Popovici, Youping Deng, Viswanath Devanarayan, Richard Judson and 101 more - Nature Biotechnology 2010 cited by 915

  9. Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

    Authors: Michèle Cavo, Evangelos Terpos, Cristina Nanni, Philippe Moreau, Suzanne Lentzsch, Sonja Zweegman, Jens Hillengaß, Monika Engelhardt, Saad Z. Usmani, David H. Vesole, Jesús F. San Miguel, Shaji Kumar, Paul G. Richardson, Joseph Mıkhael, Fernando Leal da Costa, Meletios Α. Dimopoulos, Chiara Zingaretti, Niels Abildgaard, Hartmut Goldschmidt, Robert Z. Orlowski, Wee Joo Chng, Hermann Einsele, Sagar Lonial, Bart Barlogie, Kenneth C. Anderson, S. Vincent Rajkumar, Brian G.M. Durie, Elena Zamagni - The Lancet Oncology 2017 cited by 520

  10. CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma

    Authors: Eric D. Hsi, Roxanne Steinle, Balaji Balasa, Susann Szmania, Aparna Draksharapu, Benny P. Shum, Mahrukh Huseni, David B. Powers, Amulya Nanisetti, Yin Zhang, Audie Rice, Anne van Abbema, Melanie Wong, Gao Liu, Fenghuang Zhan, Myles Dillon, Shihao Chen, Susan Rhodes, Franklin Fuh, Naoya Tsurushita, Shankar Kumar, Vladimir Vexler, John D. Shaughnessy, Bart Barlogie, Frits van Rhee, Mohamad A. Hussein, Daniel Afar, Marna Williams - Clinical Cancer Research 2008 cited by 560

  11. Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

    Authors: Saad Z. Usmani, Christoph Heuck, Alyson E. Mitchell, Jackie Szymonifka, Bijay Nair, Antje Hoering, Yazan Alsayed, Sarah Waheed, Sajjad Haider, Alejandro Restrepo, Frits van Rhee, John Crowley, Bart Barlogie - Haematologica 2012 cited by 389

  12. A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

    Authors: Paul G. Richardson, Bart Barlogie, James R. Berenson, Seema Singhal, Sundar Jagannath, David Irwin, S. Vincent Rajkumar, Gordan Srkalović, Melissa Alsina, Raymond Alexanian, David S. Siegel, Robert Z. Orlowski, David J. Kuter, Steven Limentani, Stephanie J. Lee, Teru Hideshima, Dixie‐Lee Esseltine, Michael Kauffman, Julian Adams, David P. Schenkein, Kenneth C. Anderson - New England Journal of Medicine 2003 cited by 2,641

  13. Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myeloma

    Authors: Leo Rasche, Edgardo Angtuaco, James E. McDonald, Amy Buros, Caleb Stein, Charlotte Pawlyn, Sharmilan Thanendrarajan, Carolina Schinke, Rohan Samant, Shmuel Yaccoby, Brian A. Walker, Joshua Epstein, Maurizio Zangari, Frits van Rhee, Tobias Meißner, Hartmut Goldschmidt, Kari Hemminki, Richard S. Houlston, Bart Barlogie, Faith E. Davies, Gareth J. Morgan, Niels Weinhold - Blood 2017 cited by 248

  14. The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma

    Authors: Eileen M. Boyle, Shayu Deshpande, Ruslana G. Tytarenko, Cody Ashby, Yan Wang, Michael Bauer, Sarah K. Johnson, Christopher P. Wardell, Sharmilan Thanendrarajan, Maurizio Zangari, Thierry Façon, Charles Dumontet, Bart Barlogie, Arnaldo Arbini, Even H Rustad, Francesco Maura, Ola Landgren, Fenghuang Zhan, Frits van Rhee, Carolina Schinke, Faith E. Davies, Gareth J. Morgan, Brian A. Walker - Nature Communications 2021 cited by 138

  15. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

    Authors: John D. Shaughnessy, Fenghuang Zhan, Bart Burington, Yongsheng Huang, Simona Colla, Ichiro Hanamura, Peter Stewart, Bob Kordsmeier, Christopher E. Randolph, David R. Williams, Yan Xiao, Hongwei Xu, Joshua Epstein, Elias Anaissie, Somashekar G. Krishna, Michele Cottler‐Fox, Klaus Hollmig, Abid Mohiuddin, Mauricio Pineda‐Roman, Guido Tricot, Frits van Rhee, Jeffrey R. Sawyer, Yazan Alsayed, Ronald C. Walker, Maurizio Zangari, John Crowley, Bart Barlogie - Blood 2006 cited by 916

  16. Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation

    Authors: Ichiro Hanamura, Peter Stewart, Yongsheng Huang, Fenghuang Zhan, Madhumita Santra, Jeffrey R. Sawyer, Klaus Hollmig, Maurizio Zangarri, Mauricio Pineda‐Roman, Frits van Rhee, Federica Cavallo, Bart Burington, John Crowley, Guido Tricot, Bart Barlogie, John D. Shaughnessy - Blood 2006 cited by 479

  17. Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level

    Authors: Lukas John, Alexandra M. Poos, Alexander Brobeil, Carolina Schinke, Stefanie Huhn, Nina Prokoph, Raphael Lutz, Barbara Wagner, Maurizio Zangari, Stephan M. Tirier, Jan‐Philipp Mallm, Sabrina Schumacher, Dominik Vonficht, Llorenç Solé‐Boldo, Sabine Quick, Simon Steiger, Moritz J. Przybilla, Katharina Bauer, Anja Baumann, Stefan Hemmer, Christoph Rehnitz, Christian Lückerath, Christos Sachpekidis, Gunhild Mechtersheimer, Uwe Haberkorn, Antonia Dimitrakopoulou‐Strauss, Philipp Reichert, Bart Barlogie, Carsten Müller‐Tidow, Hartmut Goldschmidt, Jens Hillengaß, Leo Rasche, Simon Haas, Frits van Rhee, Karsten Rippe, Marc S. Raab, Sandra Sauer, Niels Weinhold - Nature Communications 2023 cited by 38

  18. The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states

    Authors: Leo Rasche, Carolina Schinke, Francesco Maura, Michael Bauer, Cody Ashby, Shayu Deshpande, Alexandra M. Poos, Maurizio Zangari, Sharmilan Thanendrarajan, Faith E. Davies, Brian A. Walker, Bart Barlogie, Ola Landgren, Gareth J. Morgan, Frits van Rhee, Niels Weinhold - Nature Communications 2022 cited by 76

  19. The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma

    Authors: Erming Tian, Fenghuang Zhan, Ronald C. Walker, Erik Rasmussen, Yupo Ma, Bart Barlogie, John D. Shaughnessy - New England Journal of Medicine 2003 cited by 1,505

  20. Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma

    Authors: Christina M. Annunziata, R. Eric Davis, Yulia N. Demchenko, William Bellamy, Ana Gabrea, Fenghuang Zhan, Georg Lenz, Ichiro Hanamura, George W. Wright, Wenming Xiao, Sandeep S. Davé, Elaine M. Hurt, Bruce K. Tan, Hong Zhao, Owen Stephens, Madhumita Santra, David R. Williams, Lenny Dang, Bart Barlogie, John D. Shaughnessy, W. Michael Kuehl, Louis M. Staudt - Cancer Cell 2007 cited by 949

  21. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

    Authors: Twyla B. Bartel, Jeff Haessler, Tracy L. Brown, John D. Shaughnessy, Frits van Rhee, Elias Anaissie, Terri L. Alpe, Edgardo Angtuaco, Ronald C. Walker, Joshua Epstein, John Crowley, Bart Barlogie - Blood 2009 cited by 523

  22. Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)

    Authors: Brian G.M. Durie, Antje Hoering, Rachael Sexton, Muneer H. Abidi, Joshua Epstein, S. Vincent Rajkumar, Angela Dispenzieri, Stephen P. Kahanic, Mohan C. Thakuri, Frederic J. Reu, Christopher M. Reynolds, Robert Z. Orlowski, Bart Barlogie - Blood Cancer Journal 2020 cited by 252

  23. Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients

    Authors: Susann Szmania, Natalia Lapteva, Tarun K. Garg, Amy D Greenway, Joshuah D Lingo, Bijay Nair, Katie L. Stone, Emily Woods, Junaid Khan, Justin Stivers, Susan Panozzo, Dario Campana, William Bellamy, Molly Robbins, Joshua Epstein, Shmuel Yaccoby, Sarah Waheed, Adrian P. Gee, Michele Cottler‐Fox, Cliona M. Rooney, Bart Barlogie, Frits van Rhee - Journal of Immunotherapy 2014 cited by 180

  24. Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma

    Authors: Leo Rasche, Daisy Alapat, Manoj Kumar, Grant Gershner, James E. McDonald, Christopher P. Wardell, Rohini Samant, Rudy Van Hemert, Joshua Epstein, Anjana Williams, Sharmilan Thanendrarajan, Carolina Schinke, Michael Bauer, Cody Ashby, Ruslana G. Tytarenko, Frits van Rhee, Brian A. Walker, Maurizio Zangari, Bart Barlogie, Faith E. Davies, Gareth J. Morgan, Niels Weinhold - Leukemia 2018 cited by 152